PSMA PET CT imaging for prostate cancer
Search documents
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Seeking Alpha· 2026-03-05 05:42
Group 1 - The webinar focuses on innovations in PSMA PET CT imaging for prostate cancer, featuring key opinion leaders and subject matter experts [1] - The panel discussion is moderated by Dr. David Cade, Chief Medical Officer at Telix, and includes notable speakers from prestigious institutions [2] - The discussion aims to provide insights from a physician's perspective on advancements in imaging technology for prostate cancer [1][2] Group 2 - The speakers include Rodney Hicks, a Professor of Medicine and Chief Medical Officer at the Melbourne Theranostic Innovation Center, and Dr. Paul Yonover, Chief Data Officer at UroPartners [2] - Darren Patti serves as the Chief Operating Officer of Telix, contributing to the operational insights during the discussion [2]